With 45 pathologists and over half a million whole slide images (WSIs) produced annually, this network of London trusts deploys Aperio GT 450 DX scanners
Albuquerque, NM, July 8, 2025 – Indica Labs, the global leader in AI-powered digital pathology software and services, today announces that their Pharma Services team is offering quantitative image analysis studies designed and performed to Good Clinical Practice (GCP) standards.
Indica Labs’ Pharma Services Launches GCP-Compliant Image Analysis Service Read More »
Albuquerque, NM, April 30, 2025 – Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today an update to their Breast IHC AI suite, an image analysis tool used for the quantification of HER2, ER, PR, and Ki67 within AI-identified, tumor regions, of breast cancer tissue specimens. The HER2 algorithm will now include functionality for the detection of low and ultralow HER2 expression in breast cancer.
Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today the expansion of their macrodissection suite with the launch of CRC Macrodissect AI.
Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI Read More »
Albuquerque, NM and Hørsholm, Denmark, April 9, 2025 – Indica Labs and Visiopharm today announce the successful integration of Visiopharm’s Discovery image analysis software into Indica’s collaborative image management platform, HALO Link. The integration will enable laboratories to create a customized digital pathology ecosystem optimized for their unique image analysis and collaboration needs.
Albuquerque, NM, 8 April 2025 – Indica Labs today announces the launch of the High Dimensional Analysis module for the HALO® image analysis platform. This exciting new functionality for customers in the life sciences enables advanced phenotypic characterization and spatial analysis as well as the exploration of highly multiplexed datasets in either brightfield or fluorescence.
Albuquerque, NM and Grapevine, TX, February 4, 2025 – Indica Labs, the global leader of AI-powered digital pathology and Versant Diagnostics, an independent physician services company and proponent of next-generation digital pathology, announce today that Versant Diagnostics has chosen the HALO AP® platform from Indica Labs to further support their mission of helping world leading pathologists transition from conventional pathology to cutting edge digital technology.
Vista, CA, and Albuquerque, NM, January 8, 2025 – Leica Biosystems, a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, today announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This partnership has the potential to accelerate AI-enabled companion diagnostics (CDx) and support discoveries and treatments based on discrete or complex biomarker expression profiles which are not discernable by the human eye.
Albuquerque, NM, 19 December 2024 -Indica Labs announced today that Molecular Pathology Laboratory Network, Inc. (MPLN), a leader in laboratory medicine, hematopathology, and solid tumor oncology testing, has selected the HALO AP® platform from Indica Labs to deliver digital pathology services to both clinical reference labs and biopharma clients.
Albuquerque, NM, 11 December 2024 -Indica Labs, the global leader in AI-powered digital pathology, today announces that the Institute of Tissue Medicine and Pathology at the University of Bern, a leading university based pathology institute in Switzerland, has selected HALO AP® for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc. (AWS).
